Form 483

NeuroScience Solutions, Inc. Form 483, 2016-09-12

FDA issued a Form 483 to NeuroScience Solutions, Inc. on 2016-09-12 with 14 public-safe observations.

483· Form 483 issuedFoods & Cosmetics14 observations

NeuroScience Solutions, Inc. · Osceola, United States · Issued September 12, 2016

Overview

  • 14 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Sep 2016
21 CFR 111.153

Written procedures - labels

Cited by Amy L Mcintyre, Theresa C Klaman

12 Sep 2016
21 CFR 111.153

Written procedures - labels

Cited by Amy L Mcintyre, Theresa C Klaman

12 Sep 2016
21 CFR 111.55

Production, process controls - implement

Cited by Amy L Mcintyre, Theresa C Klaman

12 Sep 2016
21 CFR 111.55

Production, process controls - implement

Cited by Amy L Mcintyre, Theresa C Klaman

12 Sep 2016
21 CFR 111.570(b)(2)(i)

Record - person document; time of performance

Cited by Amy L Mcintyre, Theresa C Klaman

Inspected site

NSNeuroScience Solutions, Inc.Osceola, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.153Cited across public-safe Form 483 observations2x
21 CFR 111.55Cited across public-safe Form 483 observations2x
21 CFR 111.570(b)(2)(i)Cited across public-safe Form 483 observations2x
21 CFR 111.570(b)(2)(ii)(B)Cited across public-safe Form 483 observations2x
21 CFR 111.570(b)(2)(ii)(F)Cited across public-safe Form 483 observations2x
21 CFR 111.75(c)Cited across public-safe Form 483 observations2x
21 CFR 111.95(b)(1)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 14 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere